date founded

General

About Company
Almirall is a global biopharmaceutical company focused on skin health.

Industry

Sector :

Subsector :

founded date

01.01.1943

Number of employees

Company Type

For Profit

IPO status

Private

Description

Founded in 1943 and headquartered in Barcelona, Spain, Almirall develops and commercializes innovative solutions for dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis, and acne. With close to 1,800 employees and operations in over 70 countries, Almirall is dedicated to improving patients' quality of life through science, knowledge, and global healthcare partnerships.
Contacts

Contact Email

Phone number

Social url

Similar Companies
999
Adastra Pharmaceuticals

Adastra Pharmaceuticals

Adastra Pharmaceuticals is a clinical-stage oncology company that develops proprietary medicines for the treatment of various cancers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Diego, CA, USA

total rounds

10

total raised

$85M

count Of Investments

1
Grifols

Grifols

Grifols develops and sells healthcare services and solutions in 110+ countries.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Financial Services, Biotechnology

Location

Barcelona, Spain

total rounds

2

total raised

$1.4B

count Of Investments

6

count Of Exists

3
Dr. Willmar Schwabe Pharmaceuticals

Dr. Willmar Schwabe Pharmaceuticals

Schwabe Pharmaceuticals develops innovative plant-based medicines and health products to improve people's health and quality of life.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Pharmaceuticals, Biotechnology

Location

Karlsruhe, Germany
Almirall

Almirall

Almirall is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Pharmaceuticals, Biotechnology

Location

Barcelona, Spain

total rounds

1

total raised

$215.98M

count Of Investments

2

Financials

Co-Investors

People

Employee Profiles
67

Jim Berman

Pharmaceutical sales representative

Christopher Colburn

Executive director, market access

Samantha Widdicombe

Executive director, strategic communications and professional relations, almirall llc

John Manfredi

Executive director, managed markets, channel access and trade

Jacob Rasmussen

General manager uk, ireland, nordic and baltic countries

Cheryl Astrauskas

Sales representative

Katherine Boyle

Professional relations executive

Frederic Aziere

Global marketing manager psoriasis

Activity

Recent News
10
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week